US FDA establishes drug safety web page
This article was originally published in Scrip
Executive Summary
The US FDAhas fulfilled a requirement under the FDA Amendments Act by creating a web page with postmarketing drug safety information for consumers and healthcare professionals. The page is located under the drugs centre's website and includes links to drugs and biologicals with medication guides or risk evaluation and mitigation strategies, drug safety announcements and the agency's list of medicines undergoing scrutiny for specific safety issues.